Outpatient Prescription for Lower Respiratory Tract Infection
For patients with lower respiratory tract infection (LRTI) in the outpatient setting, amoxicillin (500-1000 mg every 8 hours) or tetracycline (100 mg every 12 hours) are the first-choice antibiotics, with treatment duration of 7 days. 1
Diagnostic Approach
Before prescribing antibiotics, determine if the patient truly needs them:
- Most LRTIs are self-limiting and will resolve within 1-3 weeks 1
- Consider measuring C-reactive protein (CRP) to strengthen diagnosis or exclusion of pneumonia 1
- CRP >30 mg/L with suggestive symptoms increases likelihood of pneumonia
- CRP <10 mg/L makes pneumonia less likely
Antibiotic Indications
Antibiotics are indicated in patients with LRTI who have:
- Suspected or definite pneumonia 1
- Selected exacerbations of COPD with:
- Increased dyspnea
- Increased sputum volume
- Increased sputum purulence 1
- Age >75 years with fever 1
- Cardiac failure 1
- Insulin-dependent diabetes mellitus 1
- Serious neurological disorder (stroke, etc.) 1
First-Line Antibiotic Options
For outpatient LRTI requiring antibiotics:
Option 1: Amoxicillin
Option 2: Tetracycline (Doxycycline)
Alternative Antibiotic Options
If hypersensitivity to first-line agents or high local resistance rates:
Option 3: Newer Macrolides
- Azithromycin: 500 mg daily for 3 days or 500 mg on day 1, then 250 mg daily for 5 days 1
- Clarithromycin: 250-500 mg every 12 hours for at least 5 days 1
- Note: Use only in areas with low pneumococcal macrolide resistance 1
Option 4: Amoxicillin-Clavulanate
- Dosage: For respiratory infections, 875 mg/125 mg every 12 hours 2
- Alternative: 500 mg/125 mg every 8 hours 2
- Note: Higher incidence of diarrhea compared to other options 2
Option 5: Fluoroquinolones (reserve option)
- Only when there are clinically relevant bacterial resistance rates against all first-choice agents 1
- Options: Levofloxacin or moxifloxacin 1, 3
Symptomatic Treatment
For Dry Cough
- Dextromethorphan or codeine can be prescribed for dry, bothersome cough 1
Not Recommended
- Expectorants, mucolytics, antihistamines, and bronchodilators should not be prescribed for acute LRTI in primary care 1
Monitoring and Follow-up
- Assess response at day 5-7 (improvement of symptoms) 1
- Consider temporarily adjusting dosages of chronic medications for conditions that may flare up during LRTI (asthma, COPD, cardiac failure, diabetes) 1
Important Considerations
- Be aware of local bacterial resistance rates 1
- Inform patients about the severity of their disease and its prognosis 1
- Most LRTIs are self-limiting and will last between 1-3 weeks 1
- Antibiotic treatment in uncomplicated acute bronchitis has modest benefits that don't outweigh side effects 1
- In elderly patients, antibiotic treatment may have more clinical effects than in young adults 1
Remember that appropriate antibiotic selection is crucial to minimize resistance development while effectively treating the infection.